Technical Analysis for NVTA - Invitae Corporation

Grade Last Price % Change Price Change
F 0.02 -35.59% -0.01
NVTA closed down 35.59 percent on Wednesday, February 14, 2024, on 1.6 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Spinning Top Other -35.59%
Calm After Storm Range Contraction -35.59%
Narrow Range Bar Range Contraction -35.59%
Inside Day Range Contraction -35.59%
Wide Bands Range Expansion -35.59%
Oversold Stochastic Weakness -35.59%
Calm After Storm Range Contraction -49.20%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Invitae Corporation Description

Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Biology Telehealth Telemedicine Genetics Medical Genetics Medical Test Neurological Disorders Lab Testing Molecular Diagnostics Neurology Software Tools Informatics Urological Disorders Genetic Disorder Cardiovascular Disorders

Is NVTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.34
52 Week Low 0.015
Average Volume 13,743,033
200-Day Moving Average 0.84
50-Day Moving Average 0.47
20-Day Moving Average 0.28
10-Day Moving Average 0.14
Average True Range 0.05
RSI (14) 18.03
ADX 42.37
+DI 10.24
-DI 50.93
Chandelier Exit (Long, 3 ATRs) 0.39
Chandelier Exit (Short, 3 ATRs) 0.16
Upper Bollinger Bands 0.65
Lower Bollinger Band -0.09
Percent B (%b) 0.14
BandWidth 261.16
MACD Line -0.14
MACD Signal Line -0.11
MACD Histogram -0.0297
Fundamentals Value
Market Cap 5.44 Million
Num Shares 286 Million
EPS -5.36
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.01
Price-to-Book 3.32
PEG Ratio -0.51
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.03
Resistance 3 (R3) 0.03 0.03 0.03
Resistance 2 (R2) 0.03 0.02 0.03 0.03
Resistance 1 (R1) 0.02 0.02 0.03 0.02 0.03
Pivot Point 0.02 0.02 0.02 0.02 0.02
Support 1 (S1) 0.02 0.02 0.02 0.02 0.01
Support 2 (S2) 0.01 0.01 0.01 0.01
Support 3 (S3) 0.01 0.01 0.01
Support 4 (S4) 0.01